School of Medicine

The Pulse

Congratulations to the following individuals for obtaining extramural funding from federal, state, and/or independent sources between August 1 - October 31, 2020! 

NOTE: If any information has been inadvertently omitted, please contact the editor (dflock@lsuhsc.edu) and a correction will be printed in the next issue of The Pulse. 
 
 
National Institutes of Health (R01): 
 
  • Nicholas Gilpin, PhD (Department of Physiology)
     “Role of Neuropeptides in Stress-Induced Escalation of Alcohol Drinking”
     
  • David Lefer, PhD (Cardiovascular Center of Excellence) - Multi-PI Grant with Brown University
    “Hydrogen Sulfide Regulation in Cardioprotection”  
     
  • Guoshun Wang, DVM, PhD (Department of Microbiology, Immunology and Parasitology)
    “Innate Immune Defect and Neutrophilic Inflammation in Cystic Fibrosis” 
 
 
National Institutes of Health (R21): 
 
  • Ashok Aiyar, PhD (Department of Microbiology, Immunology and Parasitology)
    “Factors that Modulate the Deleterious Effect of Ammonia Generation by Chlamydial Tryptophan Synthase”  
     
  • Muhammad Farooq, (Department of Cell Biology and Anatomy)
    “Alcohol Exposure Reverses Fear Conditioning-Induced Change in Endocannabinoid Signaling” 
     
  • Song Hong, PhD (Neuroscience Center of Excellence) Janssen Pharmaceuticals Research Foundation
    “Explore the Comparative Biology on Effects of Skin Ulceration on AD-Pathological Neurodegeneration” 
 
 
National Institutes of Health (U01): 
 
  • Nicholas Gilpin, PhD (Department of Physiology)
    “Long-Term Effects of Adolescent Alcohol on Pain” 
 
 
National Institutes of Health (UG1): 
 
  • Augusto Ochoa, MD (Stanley S. Scott Cancer Center)
    “Gulf South Minority/Underserved Clinical Trials Network (Gulf South M/U CTN) (COVID Supplement)” 
 
 
National Institutes of Health (U54): 
 
  • Allison C. Augustus-Wallace, PhD (Department of Medicine) - Multi-PI grant with Xavier University of Louisiana (previously awarded to PI Paul Gregory) 
    “Building Infrastructure Leading to Diversity II  
 
 
Foundations and National Associations: 
 
  • Nicolas Bazan, MD, PhD (Neuroscience Center of Excellence)
    Eye, Ear, Nose & Throat Foundation
    Equipment for Neuroscience Center 
 
 
Pharmaceutical and Company Grants: 
 
  • Matthew Lammi, MD (Department of Medicine/Section of Pulmonary/Critical Care and Allergy/Immunology)
    Janssen Pharmaceuticals Research Foundation
    “A Prospective, Multi-Center, Non-Interventional Study for the Identification of Biomarker Signatures for the Early Detection of Pulmonary Hypertension (PH)” 
     
  • Matthew Lammi, MD (Matthew Lammi, MD (Department of Medicine/Section of Pulmonary/Critical Care and Allergy/Immunology)
    Janssen Pharmaceuticals Research Foundation
    “Phase II/III Study: A Multi-Center, Randomized, Double-Blind, Group-Sequential, Placebo-Controlled 52-Week Period Followed by a 104-Week, Single-Arm, Open-Label Period Study in Participants with Sarcoidosis-Associated Pulmonary Hypertension 
     
  • David Lefer, PhD (Cardiovascular Center of Excellence)
    ReCor Medical Inc.
    “ReCor Medical Effects of RDN on Left Ventricular Remodeling Following Acute Myocardial Infarction 
     
  • Rebecca Lillis, MD (Department of Medicine, Section of Infectious Diseases)
    Cepheid
    “Reproducibility Evaluation of Xpress MVP Test” 
     
  • Stephen Morse, DO (Department of Medicine, Section of Nephrology)
    Biotech LLC
    “A Randomized, Multicenter, Double-Blind, Parallel, Active-Control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients with Primary Focal Segmental”